NCT05710393

Brief Summary

The aim of this study is to find a genetic link or family trait connecting persons with Hidradenitis Suppurativa (HS) to each other. As a result, discover the cause and perhaps treatment for Hidradenitis Suppurativa (HS).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 17, 2019

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

January 25, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 2, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2026

Completed
Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

6.5 years

First QC Date

January 25, 2023

Last Update Submit

March 2, 2026

Conditions

Keywords

Hidradenitis SuppurativaHSAcne inversaAbscessBoils

Outcome Measures

Primary Outcomes (1)

  • Hidradenitis Suppurativa Genetic linkage

    Determine the genetic linkage of Hidradenitis Suppurativa (HS). Measurements are based on Gene panel assays of DNA specimen (blood or saliva) to find rare variant(s) linked to HS. Specimen samples include those provided by affected participants, and when possible they're biological family. A Gene panel diagnostic determines the number of variants (or mutation) in multiple genes, potentially identifying a genetic linkage of mendelian inheritance.

    1-Day Study Participation

Secondary Outcomes (3)

  • Demographics of Participant Population

    1-Day Study Participation

  • Pattern of Affected Family

    1-Day Study Participation

  • Number of Variants Shared

    1-Day Study Participation

Study Arms (2)

Affected

(Affected) persons with a medical history of symptoms related to Hidradenitis Suppurativa.

Unaffected-control

(Unaffected) family of participants, having no history of symptoms related to Hidradenitis Suppurativa.

Eligibility Criteria

Age7 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants with a history of Hidradenitis Suppurativa, and their biological family members.

You may qualify if:

  • Participants (affected) with Hidradenitis Suppurativa and related symptoms
  • Family (unaffected) of participants with Hidradenitis Suppurativa

You may not qualify if:

  • Children under 7-years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago Medicine

Chicago, Illinois, 60637, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood (adults, approx. 8-9 mL), (pediatric, 2-4 mL); or Saliva (1.5 - 2.0 mL) specimen for DNA (Gene panel) analysis.

MeSH Terms

Conditions

Hidradenitis SuppurativaAbscessFurunculosis

Condition Hierarchy (Ancestors)

Skin Diseases, BacterialBacterial InfectionsBacterial Infections and MycosesInfectionsSkin Diseases, InfectiousSuppurationSkin DiseasesSkin and Connective Tissue DiseasesHidradenitisSweat Gland DiseasesInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsStaphylococcal Skin InfectionsStaphylococcal InfectionsGram-Positive Bacterial InfectionsFish DiseasesAnimal Diseases

Study Officials

  • Peter Nagele, MD, MSc

    University of Chicago Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2023

First Posted

February 2, 2023

Study Start

September 17, 2019

Primary Completion

February 27, 2026

Study Completion

February 27, 2026

Last Updated

March 4, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations